Results 41 to 50 of about 4,399 (136)

Test–retest reliability of clinical accommodative measures in adolescents

Optometry and Vision Science, Volume 103, Issue 2, February 2026.
ABSTRACT Purpose To determine long‐term (3 months) test–retest reliability of accommodative testing in adolescents with normal accommodative amplitude. Methods Participants aged 12 years to <17.5 years with normal accommodative amplitude (minimum of 11 diopters [D]) and binocular vision were enrolled.
Angela M. Chen, Chris Koutures, Loraine T. Sinnott, Ann Morrison, Carissa Wu, Caitlyn Lew, Matthew Vaughn, Emily K. Wiecek, Mitchell Scheiman, Lisa A. Jordan, Tawna L. Roberts, for the EPICC Study Group   +11 more
wiley   +1 more source

Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves’ orbitopathy

Thyroid Research, 2019
Background Treatment of moderate to severe Graves’ orbitopathy (GO) is based mainly on intravenous pulses of methylprednisolone. High doses of methylprednisolone can exert several adverse effects, some of which might be life-threatening. The objective of
Dorota Walasik-Szemplińska, Grzegorz Kamiński, Iwona Sudoł-Szopińska   +2 more
doaj   +1 more source

Exploring tear fluid biomarkers and the ocular surface in thyroid eye disease

Acta Ophthalmologica, Volume 104, Issue 1, Page e28-e38, February 2026.
Abstract Purpose To examine ocular surface changes and inflammatory tear fluid biomarkers in patients with thyroid eye disease (TED). Methods We included 106 Graves' disease (GD) patients (36 without TED, 32 with active and 38 with inactive TED) and 106 age‐ and sex‐matched healthy subjects for ophthalmological evaluation, including ocular surface ...
Mikael Thomassen Neset, Roy Miodini Nilsen, Kristian Løvås, Kathrine Halsøy, Håkon Reikvam, Ann‐Elin Meling Stokland, Grethe Åstrøm Ueland, Anette S. B. Wolff, Hans Christian D. Aass, Sjur Reppe, Eystein Sverre Husebye, Eyvind Rødahl, Tor Paaske Utheim, Hans Olav Ueland   +13 more
wiley   +1 more source

Thyroid associated orbitopathy

Indian Journal of Ophthalmology, 2012
Thyroid associated orbitopathy, also known as Graves′ orbitopathy, is typically a self-limiting autoimmune process associated with dysthyroid states.
Rajat Maheshwari, Ezekiel Weis
doaj   +1 more source

Single‐Cell RNA Sequencing of Thyroid Tissues Reveals Pathogenesis of Graves' Disease

Advanced Science, Volume 13, Issue 1, 5 January 2026.
Using single‐cell RNA sequencing and TCR profiling, this study constructed an immune cell atlas in thyroid tissue of Graves’ disease (GD), revealing dominant IFN‐γ‐secreting CD4+ T cells, expanded Tph and CD11c+ B cells, and enriched T/NK cells. Notably, GD thyroid follicular cells (TFCs) activated γδ T cells, which recruited cDC1 cells, suggesting a ...
Xiaoyi Zhou, Jia Cong, Rongguang Peng, Dichen Yang, Chenchen Dong, Jing Xie, Jiqi Yan, Jie Kuang, Fubin Li, Leng Siew Yeap, Xiaoyan Xie, Haolong Yin, Rulai Han, Liyun Shen, Yulin Zhou, Guang Ning, Shu Wang, Weiqing Wang, Lei Ye   +18 more
wiley   +1 more source

Clinical assessment of patients with Graves' orbitopathy [PDF]

Medicinski Glasnik Specijalne Bolnice za Bolesti Štitaste Žlezde i Bolesti Metabolizma "Zlatibor", 2011
Clinical examination is the basis of a good assessment of a patient with Graves' orbitopathy. This study gives recommendations of the European orbitopathy group related to the activity and severity of the disease. The activity of the disease is estimated
Nedeljković-Beleslin Biljana
doaj   +1 more source

Association of Individual or Family History of Autoimmune Disease With Future Development of Type 1 Diabetes

Diabetes/Metabolism Research and Reviews, Volume 42, Issue 1, January 2026.
ABSTRACT Timely diagnosis of type 1 diabetes (T1D), especially in high‐risk populations, is crucial for preventing serious health complications. T1D is a chronic progressive autoimmune disease that has presymptomatic stages that can be identified through the detection of islet autoantibodies. Given that T1D is associated with other autoimmune diseases,
Nick Thomas, Bijay Vaidya, Richard David Leslie, Daniel Agardh, Richard Oram, Dana Dabelea, Arunjot Singh, Dimitrios Chantzichristos, Marian Rewers   +8 more
wiley   +1 more source

Upper eyelid retraction disclosed after edrophonium chloride administration in a patient with Graves&#39; orbitopathy and myasthenia gravis

Clinical Ophthalmology, 2012
Hyera Kang,1,2 Yasuhiro Takahashi,1 Masayoshi Iwaki,1 Shinichi Asamura,3 Hirohiko Kakizaki,11Department of Ophthalmology, Aichi Medical University, Nagakute, Aichi, Japan; 2Department of Ophthalmology, Presbyterian Medical Center, Jeonju, Korea ...
Kang H, Takahashi Y, Iwaki M, Asamura S, Kakizaki H   +4 more
doaj  

Alemtuzumab-induced thyroid eye disease successfully treated with a single low dose of rituximab

European Thyroid Journal
Introduction: Secondary thyroid autoimmunity, especially Graves’ disease (GD), frequently develops in patients with multiple sclerosis (MS) following alemtuzumab treatment (ALTZ; anti-CD52). Thyroid eye disease (TED) can also develop, and rituximab (RTX;
Ilaria Muller, Sara Maioli, Mirco Armenti, Laura Porcaro, Nicola Currò, Elisabetta Iofrida, Lorenzo Pignataro, Jacopo Manso, Caterina Mian, Jens Geginat, Mario Salvi   +10 more
doaj   +1 more source

Demographics, Initial Clinical Presentation, and Diagnostic Practices of Thyroid Eye Disease: Insights From a Pilot Survey of Oculoplastic Surgeons

Advances in Public Health, Volume 2026, Issue 1, 2026.
Purpose Thyroid eye disease (TED) is the most common orbital disorder in adults. Its initial clinical manifestations are heterogeneous and may influence early diagnosis and management. However, limited data exist on real‐world perspectives from oculoplastic surgeons who frequently manage patients with TED.
Shiqi Hui, Lihua Luo, Zhijia Hou, Dongmei Li, Weike Zhang   +4 more
wiley   +1 more source